Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +971 (0) 4 368 1644
  • GDPR
  • Journalists
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +971 (0) 4 368 1644 from 8 AM - 5:30 PM GMT

    • Contact
    • Contact

      +971 (0) 4 368 1644
      from 8 AM - 5:30 PM GMT

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Pfizer Holds MERA Vaccines Summit to Discuss the Impact of Vaccines on Controlling Diseases in the Region
  • Middle East - Arabic
  • USA - English


News provided by

Pfizer

30 Oct, 2023, 06:00 GMT

Share this article

Share toX

Share this article

Share toX

  • The MERA Vaccines Summit brought together more than 100 physicians and healthcare professionals to Dubai to discuss a range of communicable diseases.
  • The summit educated healthcare professionals with the latest literature on vaccines, and its impact to the region's population.
  • Vaccines are critical to reducing disease burden and countering new variants of diseases, especially for those at most risk of hospitalization.

DUBAI, UAE, Oct. 30, 2023 /PRNewswire/ -- Pfizer Middle East, Russia and Africa (MERA) hosted the MERA Vaccines Summit, welcoming more than 100 physicians and healthcare professionals from around the region to Dubai, United Arab Emirates. Held this October 2023, the event covered a range of communicable diseases with leading experts. International and regional experts highlighted the global and regional burden of disease and the public health impact of vaccination, and summarized recommendations for vaccination for various patient populations.

Continue Reading
Pfizer’s MERA Vaccine Summit
Pfizer’s MERA Vaccine Summit

Experts from across the region discussed how vaccines significantly reduced the burden of many diseases in the MERA, especially those impacting younger children and older people whose immune systems are compromised. Innovations in vaccine delivery have also made preventative measures more accessible. This includes maternal vaccines, which is the vaccination of pregnant women to reduce the risk of infectious disease in infants who are too young to receive vaccines.

They also discussed how critical it is for vaccine strategies to be implemented during mass gatherings that are considered high-risk events like the Hajj pilgrim to prevent infectious disease outbreaks. In light of the pandemic, these strategies are especially important to counter the emergence of new disease variants to reduce the burden of disease in those at most risk of hospitalization or poor outcomes.

Dr Hammam Haridy, Pfizer MERA Senior Director Regional Medical & Scientific Affairs, Vaccines and Anti Virals shared, "The MERA Vaccines Summit are part of Pfizer's commitments to provide high-quality medical education to healthcare professionals throughout the region. Vaccination has become a hot topic in the last several years, and it's critical for physicians to stay updated on the latest literature to provide patients with the best possible outcomes."

Nawal Al Kaabi, Pediatric Infectious Diseases Consultant and Chair of SEHA Infectious Diseases and Infection Control Council, and Chair of the National COVID-19 Clinical Management Committee, Abu Dhabi, UAE also shared, "This summit played an important role to discuss the significance of vaccine strategies. For the public, it's important for people to know if they are at high-risk of a severe respiratory infection; to plan ahead of time in case they get sick; and to go to their healthcare provider should they get sick. With a robust plan and an informed healthcare system, we can control diseases and prevent outbreaks."

About Pfizer Inc.: Breakthroughs that Change Patients' Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Photo - https://mma.prnewswire.com/media/2259501/Pfizer.jpg

Modal title

Also from this source

International and Regional Experts Focus on RSV Prevention at Pfizer MERA Maternal Immunization Summit: Born Ready

International and Regional Experts Focus on RSV Prevention at Pfizer MERA Maternal Immunization Summit: Born Ready

More than 80 international and regional healthcare experts have convened at the Pfizer MERA Maternal Immunization Summit: Born Ready to discuss...

International and Regional Experts Address the Role of Vaccines in Disease Management during Pfizer MERA Vaccines Summit 2024

International and Regional Experts Address the Role of Vaccines in Disease Management during Pfizer MERA Vaccines Summit 2024

International and regional experts addressed more than 180 regional physicians and healthcare professionals during the annual vaccines summit, hosted ...

المزيد من الإصدارات من هذا المصدر

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

New Products & Services

New Products & Services

المزيد من البيانات الصحفية في مواضيع ذات صلة

Contact PR Newswire

  • +971 (0) 4 368 1644
    from 8 AM - 5:30 PM GMT

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+971 (0) 4 368 1644
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.